We are live on ! Find out more
JAM

JW Asset Management Portfolio holdings

AUM $244M
1-Year Est. Return 71.51%
This Fund
S&P 500
This Quarter Est. Return
+31.3%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$139M
AUM Growth
+$25.1M
Cap. Flow
-$5.51M
Cap. Flow %
-3.97%
Top 10 Hldgs %
100%
Holding
13
New
1
Increased
1
Reduced
4
Closed
5

Top Buys

Rank Stock Value
1
GRWG icon
GrowGeneration
GRWG
+$4.11M
2
ESTA icon
Establishment Labs
ESTA
+$22.2K

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$5.21M
2
AVDL
Avadel Pharmaceuticals
AVDL
+$1.85M
3
RVLP
RVL Pharmaceuticals plc Ordinary Shares
RVLP
+$864K
4
OGI
Organigram Holdings
OGI
+$766K
5
PETQ
PetIQ, Inc. Class A Common Stock
PETQ
+$516K

Sector Composition

Rank Sector Weight
1 Healthcare 67.24%
2 Consumer Discretionary 27.56%
3 Technology 4.72%
4 Consumer Staples 0.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESTA icon
1
Establishment Labs
ESTA
$2.7B
$86.2M 62.14%
3,117,485
+1,000
+0% +$22.2K
AMZN icon
2
Amazon
AMZN
$2.48T
$34.3M 24.71%
371,040
– –
MSFT icon
3
Microsoft
MSFT
$2.92T
$6.54M 4.72%
41,500
– –
GRWG icon
4
GrowGeneration
GRWG
$88.3M
$3.97M 2.86%
+967,741
New +$4.11M
HZNP
5
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.65M 2.63%
100,973
-169,802
-63% -$5.21M
PETQ
6
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$3.21M 2.31%
128,069
-20,786
-14% -$516K
SNDL icon
7
Sundial Growers
SNDL
$318M
$664K 0.48%
22,075
-8,358
-27% -$273K
ALIM
8
DELISTED
Alimera Sciences
ALIM
$209K 0.15%
27,552
-1
-0% -$6
AVDL
9
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-444,439
Closed -$1.85M
OGI
10
Organigram Holdings
OGI
$134M
– –
-55,675
Closed -$766K
RVLP
11
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
– –
-225,000
Closed -$864K
HEXO
12
DELISTED
HEXO Corp. Common Shares
HEXO
– –
-268
Closed -$59K
APHA
13
DELISTED
Aphria Inc. Common Shares
APHA
– –
-20,636
Closed -$107K

Similar funds

SC
Schulhoff & Co Cincinnati, Ohio $243M AUM 17.47% 1-Year Est. Return
HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
IFO
Independent Family Office Albany, New York $243M AUM 21.81% 1-Year Est. Return
VG
Visualize Group New York $243M AUM 6.21% 1-Year Est. Return
CP
Creekside Partners Petaluma, California $243M AUM 20.23% 1-Year Est. Return

JW Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, JW Asset Management held 13 positions worth $139M, up 22% from $114M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

JW Asset Management withdrew a net $5.51M in Q4 2019, closing 5 positions and reducing 4 holdings. Its most notable exit was Avadel Pharmaceuticals, an estimated $1.85M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, up from 65% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, JW Asset Management opened a new position in GrowGeneration worth $3.97M.

  • JW Asset Management's largest Q4 2019 buy was GrowGeneration: 967,741 shares worth $3.97M.
  • JW Asset Management added most to Establishment Labs in Q4 2019, an estimated $22.2K increase.
  • JW Asset Management's biggest Q4 2019 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $5.21M.
  • JW Asset Management fully exited Avadel Pharmaceuticals in Q4 2019, selling an estimated $1.85M.
  • JW Asset Management's ten largest holdings make up 100% of its $139M portfolio in Q4 2019.
  • JW Asset Management opened 1 new position and closed 5 in Q4 2019.
  • JW Asset Management's portfolio value rose 22% quarter-over-quarter to $139M.

Based on JW Asset Management's 13F filing for Q4 2019, filed 11 Feb 2020.